Business Wire

Edwards Lifesciences’ Unifying Generations Report Seeks to Transform Perceptions of the “Pivotal” 3rd Generation

21.6.2022 11:00:00 EEST | Business Wire | Press release

Share

Edwards Lifesciences today published ‘Unifying Generations: Building the Pathway to Intergenerational Solidarity’ – a report, based on a survey of 12,850 Europeans across generations, that demonstrates the need to change perceptions of the value of people aged over-65 and their cohesion with younger generations.

The European population is ageing. By 2040, 155 million people are expected to be over 65 1 . This demographic change is often referred to as a challenge, which gives a misleading and negative impression of the contributions of over-65s to the society,” commented Jean-Luc Lemercier, Corporate Vice President, EMEA, Canada and Latin America, Edwards Lifesciences. “The survey results demonstrate that the senior population, and especially the pivotal 3rd generation, is an active, committed and engaged contributor to cohesion within families and the community.

To provide insights on the role of the senior population in society and the benefits of intergenerational interactions, Edwards Lifesciences joined forces with experts to conduct a survey examining the perceptions and experience of intergenerational solidarity of 12,850 citizens across 6 European countries (France, Germany, Ireland, Italy, Spain, and the UK). The results formed the basis of the newly available Unifying Generations report.

In contrast to existing perceptions, the survey results highlighted the significant social contributions of the 3rd generation. They contribute to their families and communities, through volunteering (19%) and providing care to others (24%).2 Seventy-one percent (71%) of over-65s also provide significant financial support to younger people.2 Younger generation respondents stated how important they felt the support the older generation provided was in their day-to-day lives, with 83% stating it was very important or somewhat important.2

The Unifying Generations Survey gives an accurate picture of the current situation of intergenerational solidarity in several European countries. The results of this survey show a strong desire for more intergenerational interactions from both younger and older generations. The survey also presents the great value of listening, mentoring and coaching; contributing to community well-being through volunteering; sharing knowledge of new technology and digital skills; and many other ways of encouraging cooperation in a society for all ages. The survey data is a useful reference document that will encourage social organisations to promote intergenerational solidarity programs at local, national and international levels in European countries,” commented Mr. Angel Yagüe Criado, Project Manager, The Spanish Confederation of Older People’s Association (CEOMA).

Results showed that the pandemic seems to have had a negative impact on intergenerational interaction, with 40% of respondents saying they spend less time with different generations since the pandemic.2 However, one of the most positive themes that emerged from the report was the willingness to improve intergenerational interactions. Respondents were 11 times more likely to think closer relations between different generations are a good thing (77%) vs. a bad thing (7%). 2 In fact, 92% of survey respondents confirmed they were open to having a friend from a different generation.

The study suggests that extremely positive and varied intergenerational interactions are present in society and also valued by all age groups. It’s important that policies and strategies are developed that help maintain and strengthen these relations going forward,” said Prof George W Leeson, Professorial Fellow, Oxford Institute of Population Ageing, University of Oxford.

A number of different benefits of improving intergenerational interactions were also highlighted. The most important benefits identified were companionship or friendship (20%) and mental and emotional wellbeing (19%). Additionally, 23% of younger respondents believe that mentoring or educational schemes provided by national or local government would help them to do more with older generations.2

The report recommends three actions that can be considered as a result of the survey findings. They are: a campaign to transform perceptions of the value of senior people and their interactions with younger generations, greater opportunities for mentoring and knowledge sharing from older to younger generations; and schemes that help senior people interact more digitally.

Recognising and celebrating the knowledge, skills, and experiences of senior people is at the heart of the report and of promoting intergenerational solidarity,” added Jean-Luc Lemercier. “As we build back after the pandemic, we should change perceptions of the value our senior populations – particularly the pivotal 3rd generation – provide to society and the importance of protecting their health and well-being.”

To learn more and download the full report please visit https://www.edwards.com/ch-en/aboutus/unifying-generations/.

About Edwards Lifesciences

Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on LinkedIn and Twitter.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

About Unifying Generations

Unifying Generations is an initiative that springs from the company’s commitment to the patients it serves and illustrates the aspiration to create a community unified in its mission to improve the quality of life around the world.

###

1 Eurostat (2017) People in the EU – population projections, http://ec.europa.eu/eurostat/statistics-explained/index.php?-title=People_in_the_EU_-_population_projections

2 Censuswide. Unifying Generations. A survey of over 12,850 people in Europe. Survey carried out 04/04/2022 – 14/04/2022. Data on file. Survey funded by Edwards Lifesciences.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contacts:

Julie Tracol
julie_tracol@edwards.com
+41 (0)75 431 74 95

Michael George
Michael_George@edwards.com
+41 79 487 71 47

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release

Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release

Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther

TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 10:31:00 EEST | Press release

TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a tremendous leader and played a pivotal role in the growth of TVS Motor Company. The leadership transition comes as TVS Motor Company builds on strong business performance and continues to consolidate its position in India and expand its global presence. In FY2025-26, the company achieved a record performance, selling 5.9 million vehicles globally and delivering 30% revenue growt

Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 22:27:00 EEST | Press release

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye